Sue Ann is professor of Global Health, Vaccinology and Paediatric Infectious Diseases at University of Oxford and University of Siena, where she is the Head of the Institute for Global Health. Sue Ann is senior consultant for the Bill and Melinda Gates Foundation since 2012. In over 25 years of experience, she has contributed to the development of more than 20 globally licensed vaccines and pharmaceutical products. Vaccines she has worked on have saved millions of lives worldwide and reduced long term sequelae and disabilities, contributing to global health which is one of her key missions and goals. Sue Ann was part of the development of the first vaccine that gained emergency use listing by WHO, the new oral type 2 polio vaccine. Sue Ann is one of the Principal Investigators of the Oxford/AstraZeneca vaccine clinical development and was part of the development of 2 other COVID-19 vaccines.
Sue Ann was knighted Commander of the Order of the British Empire, CBE, for services to Sciences and Public Health in 2021, by Queen Elizabeth II, she is also knighted Commander of order of Rio Branco and Medical Merit of the Federal Republic of Brazil.
Sue Ann has also been contributing to teaching and capacity building in different areas and created the first Master in Vaccinology and Drug Development worldwide at the University of Siena. And as founder and Director of GRID Europe, has the pleasure to be one of the sponsors of the Master Program.